330 related articles for article (PubMed ID: 25217966)
1. The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations.
Giorgi FS; Biagioni F; Lenzi P; Frati A; Fornai F
J Neural Transm (Vienna); 2015 Jun; 122(6):849-62. PubMed ID: 25217966
[TBL] [Abstract][Full Text] [Related]
2. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis.
McMahon J; Huang X; Yang J; Komatsu M; Yue Z; Qian J; Zhu X; Huang Y
J Neurosci; 2012 Nov; 32(45):15704-14. PubMed ID: 23136410
[TBL] [Abstract][Full Text] [Related]
3. mTOR-Related Cell-Clearing Systems in Epileptic Seizures, an Update.
Limanaqi F; Biagioni F; Busceti CL; Fabrizi C; Frati A; Fornai F
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121250
[TBL] [Abstract][Full Text] [Related]
4. Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator.
Ali NH; Al-Kuraishy HM; Al-Gareeb AI; Alnaaim SA; Alexiou A; Papadakis M; Saad HM; Batiha GE
Mol Med; 2023 Oct; 29(1):142. PubMed ID: 37880579
[TBL] [Abstract][Full Text] [Related]
5. mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.
Ryskalin L; Limanaqi F; Frati A; Busceti CL; Fornai F
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061532
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin (mTOR) pathways in neurological diseases.
Wong M
Biomed J; 2013; 36(2):40-50. PubMed ID: 23644232
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.
Wong M
Epilepsia; 2010 Jan; 51(1):27-36. PubMed ID: 19817806
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.
McDaniel SS; Wong M
Neurosci Lett; 2011 Jun; 497(3):231-9. PubMed ID: 21354266
[TBL] [Abstract][Full Text] [Related]
10. mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy.
Russo E; Citraro R; Donato G; Camastra C; Iuliano R; Cuzzocrea S; Constanti A; De Sarro G
Neuropharmacology; 2013 Jun; 69():25-36. PubMed ID: 23092918
[TBL] [Abstract][Full Text] [Related]
11. The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway.
Talos DM; Sun H; Zhou X; Fitzgerald EC; Jackson MC; Klein PM; Lan VJ; Joseph A; Jensen FE
PLoS One; 2012; 7(5):e35885. PubMed ID: 22567115
[TBL] [Abstract][Full Text] [Related]
12. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.
Zeng LH; Rensing NR; Wong M
J Neurosci; 2009 May; 29(21):6964-72. PubMed ID: 19474323
[TBL] [Abstract][Full Text] [Related]
13. Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release.
Russo E; Andreozzi F; Iuliano R; Dattilo V; Procopio T; Fiume G; Mimmi S; Perrotti N; Citraro R; Sesti G; Constanti A; De Sarro G
Brain Behav Immun; 2014 Nov; 42():157-68. PubMed ID: 24998197
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of (immuno)proteasome subunits during epileptogenesis is attenuated by inhibition of the mammalian target of rapamycin pathway.
Broekaart DWM; van Scheppingen J; Geijtenbeek KW; Zuidberg MRJ; Anink JJ; Baayen JC; Mühlebner A; Aronica E; Gorter JA; van Vliet EA
Epilepsia; 2017 Aug; 58(8):1462-1472. PubMed ID: 28643873
[TBL] [Abstract][Full Text] [Related]
15. mTOR and autophagy in regulation of acute lung injury: a review and perspective.
Hu Y; Liu J; Wu YF; Lou J; Mao YY; Shen HH; Chen ZH
Microbes Infect; 2014 Sep; 16(9):727-34. PubMed ID: 25084494
[TBL] [Abstract][Full Text] [Related]
16. Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat.
Zhang B; Wong M
Epilepsia; 2012 Mar; 53(3):506-11. PubMed ID: 22242835
[TBL] [Abstract][Full Text] [Related]
17. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis.
Citraro R; Leo A; Constanti A; Russo E; De Sarro G
Pharmacol Res; 2016 May; 107():333-343. PubMed ID: 27049136
[TBL] [Abstract][Full Text] [Related]
18. Role of the mTOR signaling pathway in epilepsy.
Meng XF; Yu JT; Song JH; Chi S; Tan L
J Neurol Sci; 2013 Sep; 332(1-2):4-15. PubMed ID: 23773767
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?
Zeng LH; McDaniel S; Rensing NR; Wong M
Cell Cycle; 2010 Jun; 9(12):2281-5. PubMed ID: 20603607
[TBL] [Abstract][Full Text] [Related]
20. Role of mTOR inhibitors in epilepsy treatment.
Sadowski K; Kotulska-Jóźwiak K; Jóźwiak S
Pharmacol Rep; 2015 Jun; 67(3):636-46. PubMed ID: 25933981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
